CAR T cells produce complete responses in T-cell malignanciesJanuary 7, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersHematologyOncology
Survival data reported from largest CAR T trial in B-cell lymphomaDecember 20, 2019Lymphoma & Plasma Cell DisordersHematologyOncology
New guideline provides recommendations for radiation therapy of basal cell, squamous cell cancersDecember 18, 2019Oncology
Study halted; ‘hyperprogression’ seen with nivolumab for R/R PTCLDecember 9, 2019Lymphoma & Plasma Cell DisordersHematologyOncology
Myeloma patients over age 70 can benefit from auto-HC transplantDecember 7, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersHematologyOncology
Bispecific CAR T-cells yield high response rate in relapsed/refractory myelomaDecember 7, 2019Multiple MyelomaOncologyLymphoma & Plasma Cell Disorders
High complete response rate seen with novel CAR-T for myelomaDecember 7, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersOncologyHematology
